Ming‐Yi Wang
Impact in
- Endocrinology top 10%
- Vibrio bacteria research studies
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Immunology 16
- Galectins and Cancer Biology 7
- Aquaculture disease management and microbiota 5
-
- Vibrio bacteria research studies 7
- Co-authors
- Peng Liu (4 shared papers)Jun Xia (2 shared papers)Jingwen Zhang (1 shared paper)Tingting Qu (1 shared paper)Yimeng Song (1 shared paper)Yufeng Chu (1 shared paper)Xiaoli Shi (1 shared paper)Gang Li (1 shared paper)
- Journals
- Future Microbiology (6 papers)Microbial Pathogenesis (5 papers)INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (3 papers)International Journal of Oncology (2 papers)Current Microbiology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ming‐Yi Wang
53 papers receiving 851 citations
Peers
Comparison fields: 5 of 113
- Endocrinology 70
- Infectious Diseases 190
- Immunology 123
- Neurology 69
- Cancer Research 62
Countries citing papers authored by Ming‐Yi Wang
This map shows the geographic impact of Ming‐Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Yi Wang more than expected).
Fields of papers citing papers by Ming‐Yi Wang
This network shows the impact of papers produced by Ming‐Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Yi Wang. The network helps show where Ming‐Yi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Yi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 264 | |
| 2 | 2015 | 63 | |
| 3 | Overexpression of microRNA-21 and microRNA-126 in the patients of bronchial asthma. | 2014 | 59 |
| 4 | 2019 | 35 | |
| 5 | 2013 | 32 | |
| 6 | 2014 | 32 | |
| 7 | 2009 | 31 | |
| 8 | Conservative management of cesarean scar pregnancies: a prospective randomized controlled trial at a single center. | 2015 | 23 |
| 9 | 2021 | 22 | |
| 10 | 2014 | 18 | |
| 11 | 2010 | 17 | |
| 12 | 2018 | 16 | |
| 13 | 2020 | 16 | |
| 14 | 2017 | 15 | |
| 15 | 2015 | 15 | |
| 16 | 2023 | 14 | |
| 17 | 2024 | 13 | |
| 18 | 2015 | 13 | |
| 19 | 2021 | 12 | |
| 20 | 2011 | 12 |
About Ming‐Yi Wang
Ming‐Yi Wang is a scholar working on Immunology, Endocrinology, Surgery, Cancer Research and Molecular Biology, having authored 56 papers that have together received 874 indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (13 papers), Galectins and Cancer Biology (7 papers), Vibrio bacteria research studies (7 papers), Genomics and Phylogenetic Studies (5 papers), Aquaculture disease management and microbiota (5 papers), Microbial Community Ecology and Physiology (4 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Endocrinology (70 citations), Infectious Diseases (190 citations), Immunology (123 citations), Neurology (69 citations) and Cancer Research (62 citations). Ming‐Yi Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Peng Liu, Jun Xia, Jingwen Zhang, Tingting Qu, Yimeng Song, Yufeng Chu, Xiaoli Shi, Gang Li, Xiaozhong Gao and Jian Wang. Their work appears in journals such as Future Microbiology, Microbial Pathogenesis, INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, International Journal of Oncology and Current Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.